Research suggests that Cordyceps species may offer some benefits for respiratory and related inflammatory conditions, though the available evidence linked here is preliminary and indirect. One mouse-model study found that Cordyceps militaris appeared to improve lung function and reduce pulmonary inflammation in a COPD model, with researchers proposing that gut microbiome interactions and metabolic changes may play a role in these effects. The second study, while focused on kidney health rather than respiratory outcomes, examined Bailing Capsule derived from Cordyceps sinensis and found improvements in metabolic and tissue markers in diabetic rats, suggesting broader systemic effects of the fungus. Both studies are preclinical animal investigations with no human clinical trials represented here, which means findings cannot be directly applied to human health outcomes, and considerably more rigorous research would be needed before conclusions about efficacy in people can be drawn.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Cordyceps militaris alleviates COPD by regulating amino acid metabolism, gut ... | Other | 2025 | Supports | 72 |
| Bailing capsule (Cordyceps sinensis) ameliorates renal triglyceride accumulat... | Other | 2022 | Neutral | 67 |